Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FWKYQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,628
Award facts
- Contract value 100% obligated
- $23,628.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,628.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of medical products. As a prime contractor under the DLA Troop Support Medical framework, the company demonstrates significant capability to fulfill federal medical procurement requirements, with delivery orders ranging from minimal transactions to substantial awards exceeding $45,000. This particular order for RINVOQ, a specialized medication used in rheumatology and immunology treatment, reflects the company's role in supplying brand-name pharmaceuticals essential to military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FWKYQ?
SPE2DB25FWKYQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FWKYQ worth?
The government has obligated $23,628 on SPE2DB25FWKYQ.
Is contract SPE2DB25FWKYQ an order under another contract?
Yes. SPE2DB25FWKYQ is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKYQ competed?
The extent of competition for SPE2DB25FWKYQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award